Organogenesis Holdings Inc.
US ˙ NasdaqCM ˙ US68621F1021

SecurityORGO / Organogenesis Holdings Inc.
InstitutionQUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series
Latest Disclosed Ownership116,345 shares
Latest Disclosed Value $ 425,822
QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series ownership in ORGO / Organogenesis Holdings Inc.

On August 26, 2025 - QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series filed a NPORT-P form disclosing ownership of 116,345 shares of Organogenesis Holdings Inc. (US:ORGO) valued at $425,823 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 28, 2025 disclosing 116,345 shares of Organogenesis Holdings Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $281,555 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-08-26 2025-06-30 NP Organogenesis Holdings EC US68621F1021 116,345 0 0.00 426 -15.34 0.0096
2025-05-28 2025-03-31 NP Organogenesis Holdings EC US68621F1021 116,345 0 0.00 503 34.95 0.0121
2025-02-25 2024-12-31 NP Organogenesis Holdings EC US68621F1021 116,345 -31,295 -21.20 372 -11.85 0.0081
2024-11-26 2024-09-30 NP Organogenesis Holdings EC US68621F1021 147,640 18,725 14.53 422 17.22 0.0080
2024-08-26 2024-06-30 NP Organogenesis Holdings EC US68621F1021 128,915 0 0.00 361 -1.64 0.0074
2024-05-28 2024-03-31 NP Organogenesis Holdings EC US68621F1021 128,915 0 0.00 366 -30.55 0.0076
2024-02-26 2023-12-31 NP Organogenesis Holdings EC US68621F1021 128,915 11,832 10.11 527 41.67 0.0113
2023-11-28 2023-09-30 NP Organogenesis Holdings EC US68621F1021 117,083 -10,141 -7.97 372 -11.85 0.0097
2023-08-25 2023-06-30 NP Organogenesis Holdings EC US68621F1021 127,224 10,253 8.77 422 69.48 0.0100
2023-05-26 2023-03-31 NP Organogenesis Holdings EC US68621F1021 116,971 0 0.00 249 -20.70 0.0066
2023-02-24 2022-12-31 NP Organogenesis Holdings EC US68621F1021 116,971 -10,702 -8.38 315 -23.97 0.0087
2022-11-25 2022-09-30 NP Organogenesis Holdings EC US68621F1021 127,673 20,903 19.58 414 -20.73 0.0119
2022-08-25 2022-06-30 NP Organogenesis Holdings EC US68621F1021 106,770 8,831 9.02 521 -30.16 0.0144
2022-05-26 2022-03-31 NP Organogenesis Holdings EC US68621F1021 97,939 40,317 69.97 746 40.23 0.0174
2022-02-25 2021-12-31 NP Organogenesis Holdings EC US68621F1021 57,622 0 0.00 532 -35.12 0.0115
2021-11-24 2021-09-30 NP Organogenesis Holdings EC US68621F1021 57,622 0 0.00 821 -14.32 0.0181
2021-08-26 2021-06-30 NP Organogenesis Holdings EC US68621F1021 57,622 20,665 55.92 958 42.20 0.0205
2021-05-27 2021-03-31 NP Organogenesis Holdings EC US68621F1021 36,957 2,530 7.35 673 159.85 0.0153
2021-02-25 2020-12-31 NP Organogenesis Holdings EC US68621F1021 34,427 0 0.00 259 96.21 0.0066
2020-11-25 2020-09-30 NP Organogenesis Holdings EC US68621F1021 34,427 0 0.00 132 0.00 0.0042
2020-08-27 2020-06-30 NP Organogenesis Holdings EC US68621F1021 34,427 18,698 118.88 132 164.00 0.0043
2020-06-01 2020-03-31 NP Organogenesis Holdings EC US68621F1021 15,729 0 0.00 51 -33.33 0.0021
2020-02-27 2019-12-31 NP Organogenesis Holdings EC 68621F102 15,729 0 0.00 76 -27.18 0.0023
2019-11-27 2019-09-30 NP Organogenesis Holdings EC US68621F1021 15,729 15,729 103 0.0034
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.